These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7018728)
41. Flunarizine and verapamil inhibit chloroquine-resistant Plasmodium falciparum growth in vitro. Satayavivad J; Wongsawatkul O; Bunnag D; Tan-ariya P; Brockelman CR Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):253-8. PubMed ID: 3313742 [TBL] [Abstract][Full Text] [Related]
42. A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand. Harinasuta T; Bunnag D; Wernsdorfer WH Bull World Health Organ; 1983; 61(2):299-305. PubMed ID: 6345013 [TBL] [Abstract][Full Text] [Related]
43. In vitro sensitivity of Plasmodium falciparum to halofantrine compared with chloroquine, quinine and mefloquine in the region of Bobo-Dioulasso, Burkina Faso (West Africa). Ouédraogo JB; Dutheil Y; Tinto H; Traoré B; Zampa H; Tall F; Coulibaly SO; Guiguemdé TR Trop Med Int Health; 1998 May; 3(5):381-4. PubMed ID: 9623943 [TBL] [Abstract][Full Text] [Related]
44. Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142,490, A 4-quinolinemethanol). Pearlman EJ; Doberstyn EB; Sudsok S; Thiemanun W; Kennedy RS; Canfield CJ Am J Trop Med Hyg; 1980 Nov; 29(6):1131-7. PubMed ID: 7004214 [TBL] [Abstract][Full Text] [Related]
45. Mefloquine failure in a case of falciparum malaria induced with a multidrug-resistant isolate in a non-immune subject. Cosgriff TM; Pamplin CL; Canfield CJ; Willet GP Am J Trop Med Hyg; 1985 Jul; 34(4):692-3. PubMed ID: 3896001 [TBL] [Abstract][Full Text] [Related]
46. African serum interference in the determination of chloroquine sensitivity in Plasmodium falciparum. Carlin JM; Vande Waa JA; Jensen JB; Akood MA Z Parasitenkd; 1984; 70(5):589-97. PubMed ID: 6391006 [TBL] [Abstract][Full Text] [Related]
47. Mefloquine (WR 142,490) in the treatment of human malaria. Trenholme CM; Williams RL; Desjardins RE; Frischer H; Carson PE; Rieckmann KH; Canfield CJ Science; 1975 Nov; 190(4216):792-4. PubMed ID: 1105787 [TBL] [Abstract][Full Text] [Related]
48. In vitro response of Plasmodium falciparum to mefloquine. Studies conducted in West and East Africa. Van der Kaay HJ; Wernsdorfer WH; Froeling FM Ann Soc Belg Med Trop; 1985; 65 Suppl 2():147-53. PubMed ID: 3907532 [No Abstract] [Full Text] [Related]
49. Cloning and characterization of mefloquine-resistant Plasmodium falciparum from Thailand. Webster HK; Thaithong S; Pavanand K; Yongvanitchit K; Pinswasdi C; Boudreau EF Am J Trop Med Hyg; 1985 Nov; 34(6):1022-7. PubMed ID: 3914841 [TBL] [Abstract][Full Text] [Related]
50. [Characterization of P. falciparum strains obtained from relapsed patients]. do Rosário VE; Couto AA; Santos MA; de Souza JM Rev Inst Med Trop Sao Paulo; 1985; 27(5):274-8. PubMed ID: 3914696 [No Abstract] [Full Text] [Related]
51. Is plasmodium falciparum resistance to chloroquine reversible in absence of drug pressure? Jacquier P; Druilhe P; Felix H; Diquet B; Djibo L Lancet; 1985 Aug; 2(8449):270-1. PubMed ID: 2862437 [No Abstract] [Full Text] [Related]
52. Sensitivity in vitro of Plasmodium falciparum to chloroquine and mefloquine in two regions of Benin. Chippaux JP; Massougbodji A; Olliaro P; Gay F; Caligaris S; Danis M Trans R Soc Trop Med Hyg; 1989; 83(5):584-5. PubMed ID: 2694495 [No Abstract] [Full Text] [Related]
53. Differences in drug response of Plasmodium falciparum within an area of the Amazon region. Kremsner PG; Zotter GM; Feldmeier H; Bienzle U; Jansen-Rosseck R; Graninger W; Rocha RM; Wernsdorfer WH Trans R Soc Trop Med Hyg; 1989; 83(2):158-61. PubMed ID: 2692220 [TBL] [Abstract][Full Text] [Related]
54. Plasmodium falciparum: induction of resistance to mefloquine in cloned strains by continuous drug exposure in vitro. Oduola AM; Milhous WK; Weatherly NF; Bowdre JH; Desjardins RE Exp Parasitol; 1988 Dec; 67(2):354-60. PubMed ID: 3056740 [TBL] [Abstract][Full Text] [Related]
55. Type II mefloquine resistance in Thailand. Boudreau EF; Webster HK; Pavanand K; Thosingha L Lancet; 1982 Dec; 2(8311):1335. PubMed ID: 6128616 [No Abstract] [Full Text] [Related]
56. An ultrastructural study of the effects of mefloquine on malaria parasites. Jacobs GH; Aikawa M; Milhous WK; Rabbege JR Am J Trop Med Hyg; 1987 Jan; 36(1):9-14. PubMed ID: 3544894 [TBL] [Abstract][Full Text] [Related]
57. The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei. Merkli B; Richle R; Peters W Ann Trop Med Parasitol; 1980 Feb; 74(1):1-9. PubMed ID: 6990883 [No Abstract] [Full Text] [Related]
58. Mefloquine resistance of falciparum malaria from Tanzania enhanced by treatment. Bygbjerg IC; Schapira A; Flachs H; Gomme G; Jepsen S Lancet; 1983 Apr; 1(8327):774-5. PubMed ID: 6132124 [No Abstract] [Full Text] [Related]
59. Prophylactic activity of mefloquine hydrochloride (WR 142490) in drug-resistant malaria. Rieckmann KH; Trenholme GM; Williams RL; Carson PE; Frischer H; Desjardins RE Bull World Health Organ; 1974; 51(4):375-7. PubMed ID: 4619059 [TBL] [Abstract][Full Text] [Related]